These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 27379943)

  • 21. Development of poly(ADP-ribose) polymerase inhibitors in the treatment of BRCA-mutated breast cancer.
    Sulai NH; Tan AR
    Clin Adv Hematol Oncol; 2018 Jul; 16(7):491-501. PubMed ID: 30067621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeted therapy for the adjuvant treatment of stage III BRAF-mutated melanoma.
    Long G
    Clin Adv Hematol Oncol; 2018 Jan; 16(1):25-27. PubMed ID: 29741501
    [No Abstract]   [Full Text] [Related]  

  • 23. Cabozantinib in genitourinary malignancies.
    Zhang T; Park SE; Hong C; George DJ
    Future Oncol; 2017 Apr; 13(8):755-765. PubMed ID: 27842445
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Targeted Agents for the Frontline Management of Chronic Lymphocytic Leukemia.
    Burger JA
    Clin Adv Hematol Oncol; 2016 May; 14(5 Suppl 8):7-12. PubMed ID: 27168204
    [No Abstract]   [Full Text] [Related]  

  • 25. [-Adjuvant systemic therapy of breast carcinoma-].
    Goldhirsch A; Castiglione-Gertsch M
    Arch Gynecol Obstet; 1995; 256 Suppl():S93-103. PubMed ID: 8619668
    [No Abstract]   [Full Text] [Related]  

  • 26. [San Antonio Breast Cancer Symposium 2003. New therapeutic prospects in the treatment of early-stage breast cancer].
    Montemurro F
    Tumori; 2004; 90(1):suppl 1-16. PubMed ID: 15143995
    [No Abstract]   [Full Text] [Related]  

  • 27. American Society for Clinical Oncology 39th Annual Meeting, Chicago, Illinois, USA, 31 May to 3 June 2003: breast cancer neoadjuvant and adjuvant chemotherapy--prognostic and predictive markers.
    Earl H;
    Breast Cancer Res; 2003; 5(6):289-93. PubMed ID: 14580243
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Modern principles of chemotherapy of metastatic breast cancer].
    Syvak LA; Maĭdanevych NM; Lial'kin SA; Askolskyĭ AV; Alpat'ieva SIu; Bagirian MA; Klimanov MIu; Kasap NV
    Lik Sprava; 2011; (1-2):70-5. PubMed ID: 21954638
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Optimal front-line ALK (anaplastic lymphoma kinase) directed therapy.
    Gadgeel SM
    Lung Cancer; 2017 Jul; 109():147-148. PubMed ID: 28365051
    [No Abstract]   [Full Text] [Related]  

  • 30. Perspectives from American Society of Clinical Oncology: translational and clinical research highlights in breast and colorectal cancers.
    Fontanella C; Aprile G; Scartozzi M; Lederer B; Cascinu S; von Minckwitz G
    Future Oncol; 2014 Oct; 10(12):1901-6. PubMed ID: 25386808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clinical cancer advances 2015: Annual report on progress against cancer from the American Society of Clinical Oncology.
    Masters GA; Krilov L; Bailey HH; Brose MS; Burstein H; Diller LR; Dizon DS; Fine HA; Kalemkerian GP; Moasser M; Neuss MN; O'Day SJ; Odenike O; Ryan CJ; Schilsky RL; Schwartz GK; Venook AP; Wong SL; Patel JD
    J Clin Oncol; 2015 Mar; 33(7):786-809. PubMed ID: 25605863
    [No Abstract]   [Full Text] [Related]  

  • 32. Highlights in breast cancer from the 2015 American Society of Clinical Oncology annual meeting.
    Clin Adv Hematol Oncol; 2015 Jul; 13(7):423-7. PubMed ID: 26353037
    [No Abstract]   [Full Text] [Related]  

  • 33. Kinase Inhibitor 4 Minisymposium summary.
    Dancey JE
    Expert Rev Anticancer Ther; 2009 Jul; 9(7):891-4. PubMed ID: 19589028
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Translational and clinical research highlights from the 38th San Antonio Breast Cancer Symposium.
    Fontanella C; Puglisi F
    Future Oncol; 2016; 12(8):1005-8. PubMed ID: 26856441
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The Dual Role of Tumor-Infiltrating Lymphocytes in Human Epidermal Growth Factor Receptor 2-Positive Primary Breast Cancer: Two Sides of the Same Coin?
    Loibl S
    JAMA Oncol; 2015 Jul; 1(4):455-6. PubMed ID: 26181253
    [No Abstract]   [Full Text] [Related]  

  • 36. American Society of Hematology--47th annual meeting and exposition.
    Murch L
    IDrugs; 2006 Feb; 9(2):84-6. PubMed ID: 16523392
    [No Abstract]   [Full Text] [Related]  

  • 37. [Novel target therapies used in breast cancer management].
    Semiglazova TIu; Semiglazov VV; Filatova LV; Gershanovich ML; Chudenko VA; Latipova DKh; Luk'ianchikova VS; Dashian GA; Paltuev RM
    Vopr Onkol; 2011; 57(5):592-600. PubMed ID: 22238928
    [No Abstract]   [Full Text] [Related]  

  • 38. [Adjuvant systemic therapy of breast carcinoma].
    Wickramanayake PD; Katay I; Josting A; Diehl V
    Med Klin (Munich); 1996 Oct; 91(10):646-53. PubMed ID: 9019642
    [No Abstract]   [Full Text] [Related]  

  • 39. Highlights in GEP-NETs From the 2015 American Society of Clinical Oncology Annual Meeting.
    Clin Adv Hematol Oncol; 2015 Aug; 13(8 Suppl 8):1-19. PubMed ID: 26431403
    [No Abstract]   [Full Text] [Related]  

  • 40. Hints of future progress for HER-2 breast cancer.
    Twombly R
    J Natl Cancer Inst; 2011 Apr; 103(7):535-7. PubMed ID: 21436059
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.